United Kingdom - English - myHealthbox

milpharm limited - trimethoprim - tablets - 100mg - treatment of susceptible infections caused by trimethoprim sensitive organisms including most gram-positive and gram-negative aerobic organisms, including haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumonia, staphylococcus aureus, eschersichia coli, enterobacter, proteus and streptococcus faecalis. exceptions include anaerobic bacteria. mycobacterium tuberculosis, neisseria gonorrhoeae, pseudomonas aeruginosa and treponema pallidum. prophylaxis of recurrent urinary tract infections. consideration should be given to official guidance on the appropriate use of antibacterial agents

United Kingdom - English - VMD (Veterinary Medicines Directorate)

pfizer ltd - sulfadiazine, trimethoprim -

United Kingdom - English - VMD (Veterinary Medicines Directorate)

pfizer ltd - sulfadiazine, trimethoprim -

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875 gpo 00100 nairobi kenya - sulfadiazine, trimethoprim - tablet - sulfadiazine vet 1000 mg trimethoprim vet 200 mg. - antibacterials for systemic use: combinations of

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - trimethoprim; sulfadiazine - oral paste - trimethoprim pyrimidine active 80.0 mg/ml; sulfadiazine sulfanyl active 400.0 mg/ml - antibiotic & related - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - trimethoprim; sulfadiazine - oral bolus, chewable - trimethoprim pyrimidine active 200.0 mg/tb; sulfadiazine sulfanyl active 1000.0 mg/tb - antibiotic & related - calf | horse foal | beef calf | bovine | calf - poddy | calf - preweaning | calf - sucker | dairy calf | neonatal calf - infections of the alimentary tract | infections of the respiratory tract | infections of the urogenital tract | organisms sensitive to combination of | acute respiratory infections | bronchiseptica | bronchitis | cystitis | metritis | nephritis | pharyngitis | pneumonia | tonsillitis

Kenya - English - Pharmacy and Poisons Board

dawa limited 16633 - 00620 nairobi, kenya. - trimethoprim & sulfadiazine - tablet - trimethoprim 200mg & sulfadiazine 1.0gm per bolus - sulfadiazine and trimethoprim

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - trimethoprim; sulfadoxine - parenteral liquid/solution/suspension - trimethoprim pyrimidine active 40.0 mg/ml; sulfadoxine sulfanyl active 200.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - bacterial infection | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

United States - English - NLM (National Library of Medicine)

redpharm drug, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x), sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv) - trimethoprim 160 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets, usp and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. acute otitis m

United States - English - NLM (National Library of Medicine)

akorn - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim 1 mg in 1 ml - polymyxin b sulfate and trimethoprim ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa. * *efficacy for this organism in this organ system was studied in fewer than 10 infections. polymyxin b sulfate and trimethoprim ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.